ADAP - Adaptimmune Therapeutics plc Stock Trading

Adaptimmune Therapeutics plc(NASDAQ: ADAP) stock trading, description, contact, officers and directors.

About Adaptimmune Therapeutics plc

Not available

Stock Information

Adaptimmune Therapeutics plc Company Name:

ADAP Stock Symbol:

NASDAQ Market:

Get ADAP Alerts

News, Short Squeeze, Breakout and More Instantly...

ADAP - Adaptimmune's ADP-A2M4 nabs accelerated review in EU for soft tissue cancer

The European Medicines Agency (EMA) grants PRIME status to Adaptimmune Therapeutics' (NASDAQ: ADAP ) lead candidate ADP-A2M4, a SPEAR T-cell therapy, for the treatment of synovial sarcoma , a cancer of soft tissue such as muscle or ligaments. It also has Orphan Drug and Regenerative Med...
ADAP - Adaptimmune Granted Access to PRIority MEdicines (PRIME) Regulatory Support by the European Medicines Agency for ADP-A2M4 for the Treatment of Synovial Sarcoma

PHILADELPHIA and OXFORDSHIRE, United Kingdom, July 23, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, announced that the European Medicines Agency (EMA) has granted access to the PRIME initiative to the Company for ADP-A2M4 for...
ADAP - Adaptimmune to Report Q2 Financial Results and Business Update on Thursday, August 6, 2020

PHILADELPHIA and OXFORDSHIRE, United Kingdom, July 22, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report financial results and provide a business update for Q2 2020, before the U.S. markets open on Thursday, August 6, ...